Comprehensive & Integrative Medicine Institute

The Comprehensive & Integrative Medicine Institute (CIMI) is a South Korean research organization dedicated to the scientific validation and clinical application of integrative medicine. By combining traditional Korean medicine with modern clinical research methodologies, CIMI aims to provide evidence-based solutions for chronic and complex diseases. The institute's primary activities include conducting clinical trials for botanical extracts and herbal formulations, particularly in the fields of oncology supportive care and musculoskeletal health. CIMI operates as a bridge between academic research and commercialization, collaborating with pharmaceutical companies to bring natural product-based therapies to market. The institute is notably involved in the development of SH003, a multi-herbal extract targeting cancer-related symptoms and various malignancies.